Warning: Use of undefined constant SCRIPT_DEBUG - assumed 'SCRIPT_DEBUG' (this will throw an Error in a future version of PHP) in /homepages/37/d13561511/htdocs/tradingpattern.net/wp-includes/formatting.php on line 4144

Archiv der Kategorie ‘Illumina‘

ILMN – Illumina Reports Financial Results for First Quarter 2011

Tuesday, den 26. April 2011

ILMN – Illumina to Present at Upcoming Investment Conferences in May

Tuesday, den 26. April 2011

ILMN – Illumina to Announce First Quarter 2011 Financial Results on Tuesday, April 26, 2011

Tuesday, den 12. April 2011

ILMN – Clontech Laboratories, Inc. Releases the SMARTer(TM) Ultra Low RNA Kit for Illumina(R) Sequencing

Thursday, den 31. March 2011

Illumina (ILMN) Upgrade from Hold to Buy – Analyst rating from Auriga U.S.A

Monday, den 28. March 2011

Illumina ( ILMN ) Upgrade from Hold to Buy($75) – Analyst rating from Auriga U.S.A

Monday, den 28. March 2011

ILMN – Illumina Closes $800 Million Convertible Senior Notes

Friday, den 18. March 2011

ILMN – Illumina to Offer $800 Million Convertible Senior Notes

Monday, den 14. March 2011

ILMN – Illumina to Present at Upcoming Investment Conferences in March

Thursday, den 10. March 2011

Illumina ( ILMN ) Downgrade from Buy to Hold($75) – Analyst rating from Auriga U.S.A

Wednesday, den 9. February 2011

ILMN – Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2010

Wednesday, den 9. February 2011

Revenue of $261.3 million, a 45% increase over the $180.6 million reported in the fourth quarter of 2009. GAAP net income of $38.4 million, or $0.25 per diluted share, compared to net income of $11.7 million, or $0.09 per diluted share, for the fourth quarter of 2009. Non-GAAP net income of $40.9 million, or $0.29 […]

Citigroup upgraded shares of Illumina from hold to buy following the company’s strong guidance. With the upgrade, Citigroup raised its earnings estimates to match the company’s guidance and set a price target of $85.

Wednesday, den 26. January 2011

C

Illumina, Inc. Earnings Conference Call (Q1 2011)

Wednesday, den 26. January 2011

Scheduled to start Tue, Feb 8, 2011, 5:30 pm Eastern

Illumina sector perform – New Analyst Rating from RBC Capital Markets

Monday, den 17. January 2011

Illumina ( ILMN ) Downgrade from Outperform to Sector Perform($65) – Analyst rating from RBC Capital Mkts

Friday, den 14. January 2011

Illumina outperform – New Analyst Rating from William Blair

Monday, den 10. January 2011

Illumina buy – New Analyst Rating from UBS AG

Wednesday, den 27. October 2010

Illumina outperform – New Analyst Rating from Wedbush Morgan Securities Inc.

Thursday, den 14. October 2010

Illumina overweight – New Analyst Rating from Barclays Capital

Thursday, den 14. October 2010

Illumina outperform – New Analyst Rating from RBC Capital Markets

Friday, den 8. October 2010

Illumina (ILMN) Initial Recommendation – Outperform – Analyst rating from RBC Capital Mkts

Friday, den 8. October 2010

ILMN – Flatley interview with IBD

Tuesday, den 14. September 2010

IBD: What can be done to make this complex science more easily understood by the public so people recognize its value? Flatley: The complex science of genome sequencing? A couple of things. In the long run, we suppliers have to explain the concept of the underlying science so consumers don’t need to worry about it.

Illumina overweight – New Analyst Rating from Barclays Capital

Thursday, den 29. July 2010

Illumina (ILMN) Downgrade from Buy to Neutral – Analyst rating from GARP Research

Thursday, den 15. July 2010

Illumina “perform” – New Analyst Rating from Oppenheimer & Co. Inc.

Wednesday, den 14. July 2010

Illumina “buy” – New Analyst Rating from UBS AG

Tuesday, den 8. June 2010

Illumina (ILMN) Initial Recommendation – Mkt Perform – Analyst rating from JMP Securities

Friday, den 9. April 2010

Illumina spekulativ einsteigen – New Analyst Rating from Der Aktionaersbrief

Friday, den 15. January 2010